Top
Sign InRegister
Glenmark Pharma gets USFDA nod for Chlorzoxazone TabletsGlenmark Pharma gets USFDA nod for Chlorzoxazone Tablets
Sanofi plans to sell its equity investment in Regeneron; confirms no change to ongoing collaborationSanofi plans to sell its equity investment in Regeneron; confirms no change to ongoing collaboration
UK confirms launch of new trial for Remdesivir in coronavirusUK confirms launch of new trial for Remdesivir in coronavirus
Indoco Remedies gets USFDA nod for Succinylcholine Chloride InjectionIndoco Remedies gets USFDA nod for Succinylcholine Chloride Injection
Deepak Fertilisers forays into alcohol-based hand sanitiser spaceDeepak Fertilisers forays into alcohol-based hand sanitiser space
Glenmark to Commence Another New Phase 3 Clinical Trial India testing on Combination of Favipiravir, Umifenovir Moderate COVID-19 hospitalised patientsGlenmark to Commence Another New Phase 3 Clinical Trial India testing on Combination of Favipiravir, ...
Daiichi Sankyo Launches ENHERTU in Japan for Patients with HER2 Positive Unresectable or Metastatic Breast CancerDaiichi Sankyo Launches ENHERTU in Japan for Patients with HER2 Positive Unresectable or Metastatic...
West Pharmaceutical Services, Inc. to Join S&P 500 IndexWest Pharmaceutical Services, Inc. to Join S&P 500 Index
Dupixent met co-primary endpoints in Part A of Phase 3 trial: Regeneron, SanofiDupixent met co-primary endpoints in Part A of Phase 3 trial: Regeneron, Sanofi
Cipla, Hetero approach DCGI seeking waiver of Clinical Trial of Remdesivir in India: ReportCipla, Hetero approach DCGI seeking waiver of Clinical Trial of Remdesivir in India: Report
Bristol Myers Squibb gets EMA validation for Idecabtagene Vicleucel, CC-486Bristol Myers Squibb gets EMA validation for Idecabtagene Vicleucel, CC-486
COVID 19: Natco Pharma supports Columbia University trials for CQ tablets to prevent infectionsCOVID 19: Natco Pharma supports Columbia University trials for CQ tablets to prevent infections